Cite
HARVARD Citation
Ancuta, I. et al. (n.d.). AB0537 Superior low disease activity and remission rates when rituximab is initiated after the first anti-TNF failure: Real life data. Annals of the rheumatic diseases. p. 669. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ancuta, I. et al. (n.d.). AB0537 Superior low disease activity and remission rates when rituximab is initiated after the first anti-TNF failure: Real life data. Annals of the rheumatic diseases. p. 669. [Online].